<code id='8ECC4EFCE3'></code><style id='8ECC4EFCE3'></style>
    • <acronym id='8ECC4EFCE3'></acronym>
      <center id='8ECC4EFCE3'><center id='8ECC4EFCE3'><tfoot id='8ECC4EFCE3'></tfoot></center><abbr id='8ECC4EFCE3'><dir id='8ECC4EFCE3'><tfoot id='8ECC4EFCE3'></tfoot><noframes id='8ECC4EFCE3'>

    • <optgroup id='8ECC4EFCE3'><strike id='8ECC4EFCE3'><sup id='8ECC4EFCE3'></sup></strike><code id='8ECC4EFCE3'></code></optgroup>
        1. <b id='8ECC4EFCE3'><label id='8ECC4EFCE3'><select id='8ECC4EFCE3'><dt id='8ECC4EFCE3'><span id='8ECC4EFCE3'></span></dt></select></label></b><u id='8ECC4EFCE3'></u>
          <i id='8ECC4EFCE3'><strike id='8ECC4EFCE3'><tt id='8ECC4EFCE3'><pre id='8ECC4EFCE3'></pre></tt></strike></i>

          leisure time

          leisure time

          author:leisure time    Page View:2132
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          At least 13 dead in Texas as scorching temps continue
          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

          read more
          A new study sees potential in DNA sequencing of infants
          A new study sees potential in DNA sequencing of infants

          AdobeThere’sgrowingevidencethatDNAsequencingcanhelpdiagnosethehealthcaresystem’syoungestpatients—bab

          read more
          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more

          Lecanemab for Alzheimer's is coming. Is the health system ready?

          AneffectivetreatmentforAlzheimer’sdiseasehaslongbeenaholygrailinthepharmaceuticalindustry.InearlyJun